•
IB
IBO
Impact BioMedical, Inc.
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
48.00M
Volume
72.71K
52W High
$6.17
52W Low
$0.36
Open
$0.46
Prev Close
$0.46
Day Range
0.44 - 0.51
About Impact BioMedical, Inc.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Latest News
DSS, Inc.'s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger
Benzinga•Jun 24
Impact Biomedical Inc. Announcement Stock Activity/Pricing
GlobeNewswire Inc.•Mar 21
Impact Biomedical Inc. Announces Acquisition of Celios®, "Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality"
Benzinga•Feb 26
Contractor Wins Prestigious Award for Exquisite Ornamental Staircase
GlobeNewswire Inc.•Dec 12
ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at EMUC 2024
GlobeNewswire Inc.•Oct 25
Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebackerâ„¢ Technology Targeting Inflammatory Disease
GlobeNewswire Inc.•Oct 15
Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
Benzinga•Sep 17